Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.
Genrer
Topplistan just nu
Nr 39 i Livsvetenskaper
Antal avsnitt
244
Senaste avsnittet
8 juli 2026
Genomsnittslängd
19 min
Utgivningstakt
Nytt avsnitt varje vecka
Totalt antal minuter
4733 min
Aktiva år
2024 - 2026
Lyssna på fler avsnitt från
BioSpace
Visar 1–10 av 244 avsnitt
8 juli 2026
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
17 min
1 juli 2026
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
23 min
25 juni 2026
The Golden Triangle and the gaps: Rethinking UK biotech
20 min
24 juni 2026
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
22 min
18 juni 2026
From fragile skin to living medicine: Lessons from RDEB
22 min
17 juni 2026
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
26 min
10 juni 2026
Portugal, Spain and the new biotech frontier
21 min
10 juni 2026
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
25 min
3 juni 2026
Rethinking hair loss treatment
22 min
3 juni 2026
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck
27 min
